Filing Details

Accession Number:
0001140361-22-035561
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-30 21:30:56
Reporting Period:
2022-09-28
Accepted Time:
2022-09-30 21:30:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1559053 Prothena Corp Public Ltd Co PRTA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376117 Lars Ekman C/O Prothena Biosciences Inc
331 Oyster Point Boulevard
South San Francisco CA 94080
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share Acquisiton 2022-09-28 31,666 $6.41 31,909 No 4 M Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2022-09-28 31,666 $48.09 243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2022-09-28 31,666 $0.00 31,666 $6.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,334 2023-01-29 No 4 M Direct
Footnotes
  1. The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The shares underlying the option are fully vested exercisable as of the date hereof.